![Joshua Riggs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Riggs
Directeur Général chez
INSIGHT MOLECULAR DIAGNOSTICS INC.
Fortune : 150 391 $ au 31/08/2026
Profil
Joshua Riggs was the founder of Intelliger Consulting LLC, founded in 2015, and served as Principal from 2015 to 2020.
Mr. Riggs is currently President, Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc., starting in 2023.
Former positions include Principal at Bethesda Group LLC from 2016 to 2020.
Education includes an MBA from the University of Mississippi and an undergraduate degree from Adelphi University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 38 365 ( 0,13 % ) | 150 391 $ | 31/08/2026 |
Postes actifs de Joshua Riggs
| Sociétés | Poste | Début |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Directeur Général | 01/12/2022 |
Anciens postes connus de Joshua Riggs
| Sociétés | Poste | Fin |
|---|---|---|
Bethesda Group
 Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01/07/2020 |
Formation de Joshua Riggs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
 University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Bethesda Group
Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
